Schedule 13D ownership disclosure

CITIUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 17322U207

Event date: 2019-04-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.6100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-22-008485
Form type
SC 13D/A
Filer
Citius Pharmaceuticals, Inc.
CIK
CIK 1506251
Filed
Feb 18, 2022
Reporting period
Apr 03, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub